Tenaya Therapeutics Stock

tenayatherapeutics.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $142MM

Tenaya Therapeutics is a biopharmaceutical company focused on addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Tenaya Therapeutics before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like Tenaya Therapeutics before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Tenaya Therapeutics stock FAQs

plusminus

Can you buy Tenaya Therapeutics stock?

You can no longer buy Tenaya Therapeutics stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy Tenaya Therapeutics stock?

To invest in a private company like Tenaya Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Tenaya Therapeutics stock?

You can no longer sell stock of Tenaya Therapeutics on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell Tenaya Therapeutics stock?

If you hold private company shares of Tenaya Therapeutics - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Tenaya Therapeutics stock on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is Tenaya Therapeutics a public company?

No, Tenaya Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Tenaya Therapeutics’ stock price?

The stock price of Tenaya Therapeutics is $3.19 as of 1/18/24.
plusminus

What is Tenaya Therapeutics’ stock ticker symbol?

The ticker symbol of Tenaya Therapeutics is TNYA.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

JJ Kang Ph.D
President & Board Member
Benoit Bruneau Ph.D
Scientific Co-Founder
Sheng Ding Ph.D
Co-Founder
Timothy Hoey Ph.D
Chief Scientific Officer
Bruce Conklin MD
Scientific Co-Founder
Whittemore Tingley Ph.D
Chief Medical Officer
Faraz Ali
Board Member & Chief Executive Officer
Deepak Srivastava MD
Scientific Co-Founder & Board Member
Saptarsi Haldar MD
Scientific Co-Founder
Eric Olson Ph.D
Scientific Co-Founder

Board Members

David Goeddel Ph.D
The Column Group
Jin-Long Chen Ph.D
Deepak Srivastava MD
Faraz Ali
JJ Kang Ph.D
Anthony Philippakis MD
GV
Eli Casdin
Casdin Capital
Robert Sanders Williams MD
Tenaya Therapeutics, a company aiming to discover and develop curative therapies that target the underlying causes of heart disease, has raised $92 million.
/PRNewswire/ -- Tenaya Therapeutics, Inc., a company with a mission to discover, develop, and deliver curative therapies that target the underlying causes of...
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.